FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to veterinary science, and can be used to produce a unit multivalent combined vaccine. The vaccine contains a porcine circovirus type 2 antigen that is a protein coded by a DNA sequence which is at least 80% identical to ORF3 of porcine circovirus type 2, and one porcine reproductive and respiratory syndrome virus, and one or more pharmaceutically acceptable carriers. The group of inventions also refers to using one dose of the multivalent combined vaccine.
EFFECT: using this group enables to produce the synergetic effect of administering the combination of PCV2 ORF2 and InglVac PRRS MLV in the same dose of the vaccine to relief the symptoms related to porcine circovirus type 2 infection.
16 cl, 20 dwg, 24 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MULTIVALENT IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING THESE COMPOSITIONS | 2006 |
|
RU2577129C2 |
| PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS OF SUCH COMPOSITIONS PRODUCTION | 2005 |
|
RU2620968C9 |
| PCV2 IMMUNOGENIC COMPOSITIONS AND METHODS FOR PRODUCING THESE COMPOSITIONS | 2011 |
|
RU2575615C2 |
| IMMUNOGENIC COMPOSITIONS PCV2 AND METHODS FOR PRODUCING SUCH COMPOSITIONS | 2005 |
|
RU2435854C2 |
| PORCINE CIRCOVIRUS TYPE 3 (PCV3) VACCINES, PRODUCTION AND USE THEREOF | 2020 |
|
RU2813989C2 |
| TREATING PRDC IN GILTS | 2008 |
|
RU2522849C2 |
| PCV2B DIVERGENT VACCINE COMPOSITION AND METHODS OF USE | 2014 |
|
RU2662685C2 |
| IMMUNOGENIC COMPOSITIONS FOR IMMUNIZATION OF PIGS AGAINST CIRCOVIRUS TYPE 3 AND METHODS OF PRDUCTION AND APPLICATION THEREOF | 2016 |
|
RU2744193C2 |
| RELIEVING CONCURRENT INFECTIONS IN PIGS USING PCV2 ANTIGEN | 2008 |
|
RU2491092C2 |
| FUSED POLYPEPTIDES AND VACCINES | 2014 |
|
RU2699006C2 |
